[
    [
        {
            "time": "2018-03-15",
            "original_text": "Amgen Announces Top-Line Data From Remicade Biosimilar Study",
            "features": {
                "keywords": [
                    "Amgen",
                    "Top-Line Data",
                    "Remicade",
                    "Biosimilar",
                    "Study"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Amgen Announces Top-Line Data From Remicade Biosimilar Study",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities",
            "features": {
                "keywords": [
                    "Healthcare",
                    "Drug Pricing",
                    "Concerns",
                    "Valuations",
                    "Opportunities"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]